{"id":"W2545627348","doi":"10.1212/wnl.80.7_supplement.pl02.002","title":"Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio (PL02.002)","year":2013,"lang":"en","type":"article","venue":"Neurology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Glioblastoma; Progression-free survival; Oncology; Radiation therapy; Overall survival; Internal medicine; Chemotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002351884,0.002193863,0.002735936,0.0006215157,0.0005003595,0.001194841,0.001701316,0.001743642,0.003334171],"category_scores_gemma":[0.001402058,0.0007992781,0.001691746,0.0006047598,0.00126662,0.001172204,0.0005287416,0.004776406,0.001096028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001805738,"about_ca_system_score_gemma":0.002659546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003177505,"about_ca_topic_score_gemma":0.009325419,"domain_scores_codex":[0.999285,0.0003662368,0.0000392229,0.0001202435,0.00005940067,0.0001298447],"domain_scores_gemma":[0.9986695,0.0002109104,0.0002864243,0.00008444759,0.00007233304,0.0006763076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9192383,0.02687198,0.002819821,0.000357225,0.001761777,0.0001898121,0.0001115253,0.00123118,0.01083211,0.0001401099,0.002480764,0.03396529],"study_design_scores_gemma":[0.7443084,0.2439051,0.006839399,0.0000286912,0.0007713334,0.0001868207,0.00004048525,0.0008320508,0.001678759,0.0001532801,0.00122787,0.00002788548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911527,0.002301378,0.0004932259,0.0007390542,0.0003217109,0.001880243,0.001360619,0.0001250463,0.001625989],"genre_scores_gemma":[0.987145,0.001747941,0.001884712,0.001058348,0.0003356451,0.002004271,0.003302279,0.00005688885,0.002465028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003334171,"threshold_uncertainty_score":0.01310158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.022404835698368,"score_gpt":0.3046375881890075,"score_spread":0.2822327524906395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}